Clinical Trial Update: A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013) [Phase 2]

View source ↗

Summary

This clinical trial update reports that Merck's Tulisokibart (MK-7240) is currently recruiting for a Phase 2 study in radiographic axial spondyloarthritis (MK-7…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiographic Axial Spondyloarthritis

Drugs mentioned

• Tulisokibart (MK-7240) (tulisokibart)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Radiographic Axial Spondyloarthritis | Phase 2 | Status: RECRUITING